NCT06125119View on ClinicalTrials.gov

Development of Minimally Invasive Methodology for Diabetyping to Personalise Treatment to Realise Remission and Reversal of Type 2 Diabetes

RecruitingOBSERVATIONAL

Enrollment

57

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Type 2 Diabetes

Trial Locations (1)

Unknown

RECRUITING

Reinier Haga, Leiden

All Listed Sponsors

lead

TNO

OTHER